Bellerophon Therapeutics LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bellerophon Therapeutics LLC
CIK #0001600132
EDGAR Form CIK 2011 - 2026
10-K [0001600132]
10-Q [0001600132]
3 [0001600132]
4 [0001600132]
5 [0001600132]
8-K [0001600132]
D [0001600132]
SC 13D [0001600132]
SC 13G [0001600132]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nelson Michael Aaron Bellerophon Therapeutics Inc [2024-03-01]
Lepercq de Neuflize Asset Management LLC Bellerophon Therapeutics Inc [2024-01-26]
Nelson Michael Aaron Bellerophon Therapeutics Inc [2024-01-26]
Janus Henderson Group PLC Bellerophon Therapeutics Inc [2023-05-25]
Tang Capital Partners LP Bellerophon Therapeutics Inc [2023-03-17]
Perceptive Advisors LLC Bellerophon Therapeutics Inc [2023-03-14]
Puissance Life Science Opportunities Fund VI Bellerophon Therapeutics Inc [2020-05-22]
Sabby Management LLC Bellerophon Therapeutics Inc [2020-03-30]
Bellerophon Therapeutics Inc Venrock Healthcare Capital Partners II LP [2017-10-10]
CVI Investments Inc Bellerophon Therapeutics Inc [2017-05-18]
View All
Form 3/4/5 Subject 2011 - 2026
Puissance Life Science Opportunities Fund VI
Puissance Capital Fund GP LLC
Puissance Capital Management LP
Bellerophon Therapeutics LLC
Wang Theodore T
Kim Bobae
Shah Parag Suresh
Dekker Martin
Bruder Scott P
Teufel Crispin
Cloyd Mary Ann
Amin Naseem
Fernandes Peter
Laccona Nicholas
Puissance Capital Management GP LLC
Peacock Jonathan M
New Mountain Investments II LLC
New Mountain Capital LLC
Klinsky Steven B
FARES Wassim
Bennett Matthew
Moura Andre V
Puissance Cross-Border Opportunities III LLC
Tenenbaum Fabian
Korner Assaf
Shah Nimish P
VHCP Management III LLC
Venrock Associates IV L P
Venrock Healthcare Capital Partners III LP
VHCP Co-Investment Holdings III LLC
Venrock Entrepreneurs Fund IV L P
Venrock Partners Management LLC
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
Venrock Healthcare Capital Partners II LP
VEF Management IV LLC
Venrock Partners LP
Koh Bong Y
Venrock Management IV LLC
Edmonds Amy
Tasse Daniel
Luehring Jens
Quinn Deborah
Linde North America Inc
Schoeps Megan
Weinstein Adam
Holt Matthew S
Abrams David
Agrawal Amit
Meglasson Martin
Huennekens R Scott
Naidu Manesh
Heyrman Reinilde
New Mountain Partners II Special AIV-A LP
New Mountain Partners II AIV-B LP
Allegheny New Mountain Partners L P
New Mountain Partners II AIV-A LP
New Mountain Affiliated Investors II LP
Nelsen Robert
Bybee Clinton
Arch Venture Partners VI LP
Arch Venture Fund VI LP
Arch Venture Partners VI LLC
Crandell Keith
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Bellerophon Therapeutics LLC BLPH
Common Stock
2023-10-13 Sell 1,076,841 $0.10 107,684
Bellerophon Therapeutics LLC BLPH
Common Stock
2023-06-07 Sell 134,421 $0.83 111,569
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 14,607 $0.00
Bellerophon Therapeutics LLC BLPH
Common Stock
2023-06-07 Grant 47,578 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 100,000 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 50,000 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 50,000 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 14,607 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 50,000 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 14,607 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-06-07 Grant 14,607 $0.00
Bellerophon Therapeutics LLC BLPH
Common Stock
2023-05-18 Sell 9,455 $10.00 94,550
Bellerophon Therapeutics LLC BLPH
Common Stock
2023-05-18 Sell 560,000 $9.46 5,297,600
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-05-18 Option exercise 266 $0.00
Bellerophon Therapeutics LLC BLPH
Common Stock
2023-05-18 Option exercise 1,022 $7.50 7,665
Bellerophon Therapeutics LLC BLPH
Common Stock
2023-05-18 Option exercise 266 $7.35 1,955
Bellerophon Therapeutics LLC BLPH
Stock Options (Right to Buy) · derivative
2023-05-18 Option exercise 1,022 $0.00
Bellerophon Therapeutics LLC BLPH
Stock Options (right to buy) · derivative
2023-02-10 Grant 50,000 $1.52 76,000
Bellerophon Therapeutics LLC BLPH
Stock Options (right to buy) · derivative
2023-02-10 Grant 100,000 $1.52 152,000
Bellerophon Therapeutics LLC BLPH
Stock Options (right to buy) · derivative
2023-02-10 Grant 29,000 $1.52 44,080
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com